Surfactin Induces Apoptosis and G2/M Arrest in Human Breast Cancer MCF-7 Cells Through Cell Cycle Factor Regulation

Kameda, Y., Oira, S., Matsui, K., & Hase, T. (1974). Anti-tumor activity of Bacillus natto. V. Isolation and characterization of surfactin in the culture medium of Bacillus natto KMD 2311. Chemical and Pharmaceutical Bulletin, 22, 938–944.

Ahimou, F., Jacques, P., & Deleu, M. (2001). Surfactin and iturin A effects on Bacillus subtilis surface hydrophobicity. Enzyme and Microbial Technology, 27, 749–754.

Kim, K., Jung, S. Y., Lee, D. K., Jung, J. K., Park, J. K., Kim, D. K., et al. (1998). Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2. Biochemical Pharmacology, 55, 975–985.

Kikuchi, T., & Hasumi, K. (2002). Enhancement of plasminogen activation by surfactin C: Augmentation of fibrinolysis invitro and in vivo. Biochimica et Biophysica Acta, 1596, 234–245.

Singh, P., & Cameotra, S. S. (2004). Potential applications of microbial surfactants in biomedical sciences. Trends in Biotechnology, 22, 142–146.

Vollenbroich, D., Pauli, G., Ozel, M., & Vater, J. (1997). Antimycoplasma properties and applications in cell culture of surfactin, a lipopeptide antibiotic from Bacillus subtilis. Applied and Environmental Microbiology, 63, 44–49.

Cao, X. H., Liao, Z. Y., Wang, C. L., Cai, P., Yang, W. Y., Lu, M. F., et al. (2009). Purification and anti-tumor activity of a lipopeptide biosurfactant produced by Bacillus natto TK-1. Biotechnology and Applied Biochemistry, 52, 97–106.

Kalai, M., Lamkanfi, M., Denecker, L., Boogmans, M., Lippens, S., Meeus, A., et al. (2003). Regulation of the expression and processing of caspase-12. Journal of Cell Biology, 162, 457–467.

Reed, J. (2001). Apoptosis-regulating proteins as targets for drug discovery. Trends in Molecular Medicine, 7, 314–319.

Reed, J. (2003). Apoptosis-targeted therapies for cancer. Cancer Cell, 3, 17–22.

Sergeev, I. N. (2005). Calcium signaling in cancer and vitamin D. Journal of Steroid Biochemistry and Molecular Biology, 97, 145–151.

Ye, J. L., Mao, W. P., Wu, A. L., Zhang, N. N., Zhang, C., Yu, Y. J., et al. (2007). Cadmium-induced apoptosis in human normal liver L-02 cells by acting on mitochondria and regulating Ca2+ signals. Environmental Toxicology and Pharmacology, 24, 45–50.

Sergeev, I. N., Li, S. M., Colby, J. L., Ho, C. T., & Dushenkov, S. (2006). Polymethoxylated flavones induce Ca2+-mediated apoptosis in breast cancer cells. Life Sciences, 80, 245–253.

Antonella, M., Francesca, B., Claudia, B., Ludovica, G., Antonella, T., Simona, B., et al. (2006). Conjugated linoleic acid induces apoptosis in MDA-MB-231 breast cancer cells through ERK/MAPK signalling and mitochondrial pathway. Cancer Letters, 234, 149–157.

Danica, R., Christine, M. C., Tagvor, G. N., Motoyasu, S., Matthew, D. R., Suzanne, D. C., et al. (2003). Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cells. Experimental Cell Research, 287, 397–410.

Vousden, K. H., & Lu, X. (2002). Live or let die: the cell’s response to p53. Nature Reviews Cancer, 2, 594–604.

Yang, F., von Knethen, A., & Brune, B. (2000). Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21WAF1/CIP1. Journal of Leukocyte Biology, 68, 916–922.

Charrier-Savournin, F. B., Chateau, M. T., Gire, V., Sedivy, J., Piette, J., & Dulic, V. (2004). p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Molecular Biology of the Cell, 15, 3965–3976.

Liang, Y. C., Tsai, S. H., Chen, L., Lin-Shiau, S. Y., & Lin, J. K. (2003). Esveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochemical Pharmacology, 65, 1053–1060.

Takizawa, C. G., & Morgan, D. O. (2000). Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C. Current Opinion in Cell Biology, 12, 658–665.

Shukla, S., & Gupta, S. (2007). Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle, 6, 1102–1114.

Kern, J. C., & Kehrer, J. P. (2002). Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis. Chemico-Biological Interactions, 139, 79–95.

Zhang, G. S., Zhou, G. B., & Dai, C. W. (2004). Upregulation and activation of caspase-3 or caspase-8 and elevation of intracellular free calcium mediated apoptosis of indomethacin-induced K562 cells. Chinese Medical Journal, 117, 978–984.

Wang, C. L., Ng, T. B., Yuan, F., Liu, Z. K., & Liu, F. (2007). Induction of apoptosis in human leukemia K562 cells by cyclic lipopeptide from Bacillus subtilis natto T-2. Peptides, 28, 1344–1350.

Kaufmann, S. H., & Hengartner, M. O. (2001). Programmed cell death: Alive and well in the new millennium. Trends in Cell Biology, 11, 526–534.

Lee, E. O., Kwon, B. M., Song, G. Y., Chae, C. H., Kim, H. M., Shim, I. S., et al. (2004). Heyneanol A induces apoptosis via cytochrome c release and caspase activation in human leukemic U937 cells. Life Sciences, 74, 2313–2326.

Woo, S. H., Park, I. C., Park, M. J., Lee, H. C., Lee, S. J., Chun, Y. J., et al. (2002). Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells. International Journal of Oncology, 21, 57–63.

Anuradha, C. D., Kanno, S., & Hirano, S. (2001). Oxidative damage to mitochondria is a preliminary step to caspase-3 activation in fluoride-induced apoptosis in HL-60 cells. Free Radical Biology and Medicine, 31, 367–373.

Hsu, S. S., Huang, C. J., Cheng, H. H., Chou, C. T., Lee, H. Y., Wang, J. L., et al. (2007). Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells. Toxicology, 231, 21–29.

Agrawal, S., Agarwal, M. L., Chatterjee-Kishore, M., Stark, G. R., & Chisolm, G. M. (2005). Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosis. Molecular and Cellular Biology, 22, 1981–1992.

Mahyar-Roemer, M., & Roemer, K. (2001). p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene, 20, 3387–3398.

Agarwal, M. L., Agarwal, A., Taylor, W. R., & Stark, G. R. (1995). p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proceedings of the National Academy of Sciences USA, 92, 8493–8497.

Hartwell, L. H., & Kastan, M. B. (1994). Cell cycle control and cancer. Science, 266, 1821–1828.

Molinari, M. (2000). Cell cycle checkpoints and their inactivation in human cancer. Cell Proliferation, 33, 261–274.